Reversal of cisplatin resistance in human colon cancer cells by silencing of<em>GOLPH</em>3 gene expression

WANG Chunxiao; QIU Chengzhi; HONG Zhongshi

doi:10.19401/j.cnki.1007-3639.2019.11.004

您当前的位置：

首页 >

文章列表页 >

Reversal of cisplatin resistance in human colon cancer cells by silencing ofGOLPH3 gene expression

更新时间：2026-01-27

- Reversal of cisplatin resistance in human colon cancer cells by silencing ofGOLPH3 gene expression
- China Oncology Issue 11, Pages: 862-868(2019)
- 作者机构：
  
  福建医科大学附属第二医院普外科,福建,泉州,362000
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2019.11.004
  CLC：
- Published Online：10 December 2019，
  
  Published：10 December 2019
- 稿件说明：
移动端阅览
王春晓, 邱成志, 洪钟时. 沉默

WANG Chunxiao, QIU Chengzhi, HONG Zhongshi. Reversal of cisplatin resistance in human colon cancer cells by silencing ofGOLPH3 gene expression[J]. China Oncology, 2019, (11): 862-868.
王春晓, 邱成志, 洪钟时. 沉默 DOI： 10.19401/j.cnki.1007-3639.2019.11.004.

WANG Chunxiao, QIU Chengzhi, HONG Zhongshi. Reversal of cisplatin resistance in human colon cancer cells by silencing ofGOLPH3 gene expression[J]. China Oncology, 2019, (11): 862-868. DOI： 10.19401/j.cnki.1007-3639.2019.11.004.

摘要

背景与目的：化疗是结肠癌的重要治疗方法之一，其方案常含有铂类药物，而化疗耐药会影响结肠癌疗效和预后，其发生机制与基因异常表达有关。高尔基磷酸化蛋白3（Golgi phosphoprotein 3，GOLPH3）是一个癌基因，在结肠癌组织中存在过表达，可促进结肠癌细胞的增殖，与预后不良相关。目前，GOLPH3基因的高表达与结肠癌对铂类耐药的相关性尚不明确。探讨沉默GOLPH3基因逆转人结肠癌HT29细胞对顺铂的化疗耐药效应和机制。方法：HT29细胞分为5组。① 对照组：人结肠癌HT29细胞；② 转染组：siRNA-GOLPH3转染HT29细胞；③ 实验组1：经顺铂处理的HT29细胞；④ 实验组2：经顺铂处理的siRNA-GOLPH3转染HT29细胞；⑤ 实验组3：经顺铂和细胞外调节蛋白激酶（extracellular signal-regulated protein kinases，ERK）1/2抑制剂PD98059处理的HT29细胞。四甲基偶氮唑蓝（methyl thiazolyl tetrazolium，MTT）法、平板克隆形成实验检测各组结肠癌HT29细胞增殖及克隆形成能力。蛋白质印迹法（Western blot）检测GOLPH3、P-糖蛋白（P-glycoprotein，P-gp）、ERK1/2和pERK1/2蛋白的表达。结果：经顺铂处理后，实验组1、实验组2的细胞在波长490 nm处的吸光度（D）值均显著低于对照组（P0.05），实验组2的D

490

值显著低于实验组1（P0.001）；实验组1和实验组2的细胞集落数均显著低于对照组（P0.01），实验组2的细胞集落数显著低于实验组1（P0.001）。实验组1的P-gp、GOLPH3、pERK1/2蛋白表达量显著高于实验组2（P0.01）；实验组3的P-gp蛋白表达量较实验组1显著降低（P0.01）。结论：沉默GOLPH3基因可通过抑制丝裂原活化蛋白激酶/细胞外信号调节激酶（mitogen-activated protein kinase/extracellular signal-regulated kinase，MAPK/ERK）信号通路逆转HT29结肠癌细胞对顺铂化疗的耐药性。

Abstract

Background and purpose: Chemotherapy is an important treatment for colon cancer

which often consists of platinum drugs. However

chemotherapy resistance can affect efficacy of drug and prognosis of patient with colon cancer

and its mechanism is

related to abnormal gene expression. Golgi phosphoprotein 3 (GOLPH3) is a new oncogene

which is overexpressed in colon cancer tissue. It can promote the proliferation of colon cancer cells

and is associated with poor prognosis. At present

the relationship between the GOLPH3 gene overexpression and the resistance to platinum drugs in colon cancer is still unknown. This study aimed to investigate the effect of GOLPH3 gene silencing on reversing cisplatin resistance and its mechanism in human colon cell HT29. Methods: Colon cancer cells were divided into five groups. ① Control group: HT29 human colon cancer cells; ② Transfection group: GOLPH3 gene silencing of HT29 cells by siRNA; ③ Experimental group 1: HT29 cells treated with cisplatin; ④ Experimental group 2: HT29 siRNA-GOLPH3 transfected cells treated with cisplatin; ⑤ Experimental group 3: HT29 cells treated with cisplatin and extracellular regulated protein kinases (ERK1/2) inhibitor PD98059. The proliferation and colony formation capability of HT29 cell were measured respectively by methyl thiazolyl tetrazolium (MTT) and plate colony formation assays. The expressions of GOLPH3、P-gp、ERK1/2 and pERK1/2 in HT29 cell were detected by Western blot. Results: Absorbance (D) at 490 nm in experimental group 1 and experimental group 2 was significantly lower than that in the control group (P0.05)

while the D

490

value in experimental group 2 was significantly decreased compared with experimental group 1 (P0.01). The numbers of colony count in experimental group 1 and experimental group 2 were significantly lower than that in the control group (P0.01)

while the number of colony count in experimental group 2 was significantly decreased compared with experimental group 1 (P0.001). Compared with experimental group 1

the expressions of GOLPH3

P-gp and pERK1/2 proteins in experimental group 2 were significantly decreased (P0.01). The expression of P-gp protein in experimental group 3 was significantly lower than that in experimental group 1 (P0.01). Conclusi

on: Silencing of GOLPH3 gene could reverse the resistance of human colon cancer HT29 cells to cisplatin by deactivating mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway.

关键词

Keywords

references

Views

1668

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

AI问答

⁰

Reversal of cisplatin resistance in human colon cancer cells by silencing ofGOLPH3 gene expression

DOI：10.19401/j.cnki.1007-3639.2019.11.004

摘要

Abstract

关键词

Keywords

references